New diarylsulfonamide inhibitors of Leishmania infantum amastigotes

New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Parasitol Drugs Drug Resist
Hlavní autoři: González, Myriam, Alcolea, Pedro José, Álvarez, Raquel, Medarde, Manuel, Larraga, Vicente, Peláez, Rafael
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Regular article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8142021/
https://ncbi.nlm.nih.gov/pubmed/34015753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.02.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky